Filing Details

Accession Number:
0001104659-17-037045
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-01 20:49:21
Reporting Period:
2017-05-30
Filing Date:
2017-06-01
Accepted Time:
2017-06-01 20:49:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641640 Nabriva Therapeutics Ag NBRV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1554194 Harrison George Talbot 1000 Continental Drive
Suite 600
King Of Prussia PA 19406
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2017-05-30 110 $101.50 3,449 No 4 S Direct
Common Shares Disposition 2017-05-30 100 $101.00 3,349 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The common shares whose sale is reported on this line are represented by American Depositary Shares ("ADSs"). Each ADS represents one tenth (1/10) of a common share of Nabriva Therapeutics AG. The reporting person may hold both common shares and ADSs representing common shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of common shares.
  2. The price of $101.50 per common share was derived from the sale price on May 30, 2017, of $10.15 per ADS, multiplied by ten.
  3. The price of $101.00 per common share was derived from the sale price on May 30, 2017, of $10.10 per ADS, multiplied by ten.